Plasminogen

DRUG2 trials

Sponsors

Kedrion S.p.A., Assistance Publique - Hôpitaux de Paris

Conditions

Ligneous ConjunctivitisSepsis

Phase 2

Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial

Not yet recruitingNCT06381661

Assistance Publique - Hôpitaux de ParisSepsis

Start: 2026-05-01End: 2031-05-01Target: 2000Updated: 2026-01-27

Unknown Phase

Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient Population

Kedrion S.p.A.Ligneous Conjunctivitis

Updated: 2023-10-05